GMAB

Genmab A/SHealthcareMkt Cap $16.1B

Distillfolio Position

2026-03-25

Long #10

Score +0.3365

Weight 3.4%

13F HF

-0.001×1

13F AM

+0.002×0.3

13F Other

-0.003×0.1

Insider

+1.000×0.3

Congress

0.000×0.3

Analyst

0.000×0.3

Short Int

+0.123×0.3

ARK

0.000×0.3

13F · Hedge Fund

2025-09-30 → 2025-12-31 · top 5 of 23 funds

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
$111.7M → $153.3M
+$41.6M
TWO SIGMA ADVISERS, LP
$43.9M → $10.5M
-$33.5M
RENAISSANCE TECHNOLOGIES LLC
$86.5M → $107.6M
+$21.0M
Alyeska Investment Group, L.P.
$0.0M → $15.6M
+$15.6M
TWO SIGMA INVESTMENTS, LP
$42.7M → $27.6M
-$15.1M

13F · Asset Manager

2025-09-30 → 2025-12-31 · top 5 of 32 managers

BlackRock, Inc.
$105.8M → $141.5M
+$35.7M
Pictet Asset Management Holding SA
$0.0M → $33.8M
+$33.8M
FIRST TRUST ADVISORS LP
$51.8M → $41.1M
-$10.6M
FEDERATED HERMES, INC.
$13.0M → $20.9M
+$8.0M
Russell Investments Group, Ltd.
$25.2M → $21.9M
-$3.3M

13F · Other Institutional

2025-09-30 → 2025-12-31 · top 5 of 21 institutions

SUSQUEHANNA INTERNATIONAL GROUP, LLP
Other
$551K → $18.9M
+$18.3M
GOLDMAN SACHS GROUP INC
Bank
$34.3M → $41.1M
+$6.8M
MORGAN STANLEY
Bank
$51.4M → $56.5M
+$5.1M
ROYAL BANK OF CANADA
Bank
$0.0M → $4.5M
+$4.5M
JPMORGAN CHASE & CO
Bank
$3.6M → $7.0M
+$3.4M

Insider Transactions

2025-12-29 · 2 most recent transactions

BuyOther
Genmab A/S
2025-12-29
$7.5B
BuyOther
Genmab A/S
2025-12-26
$14.1M

Congressional Trades

—

No congressional transactions

Analyst Ratings

2026-03-02 · 60d ·3 Bullish0 Bearish0 Neutral

Bullish
Wells Fargo
2026-03-02
Overweight
Bullish
Guggenheim
2026-02-23
Buy
Bullish
HC Wainwright & Co.
2026-02-18
Buy

Short Interest

2025-12-31 → 2026-02-27 · 5 periods

2026-02-27
8.70M shares short
4.62d
-1.60d
2026-02-13
7.90M shares short
6.23d
+2.31d
2026-01-30
8.41M shares short
3.91d
-1.68d
2026-01-15
9.91M shares short
5.59d
-2.33d
2025-12-31
11.13M shares short
7.92d

ARK Holdings

—

Not held by any ARK ETF